Global Artificial Saliva Market 2023: Oral Spray Product Type Segment to Register the Highest Segmental CAGR of 14.7% | PMR

Artificial saliva Market is a synthetic substitute for natural saliva that is used to treat dry mouth (xerostomia) and other conditions that affect the production of saliva. Dry mouth can be caused by a variety of factors, including medications, radiation therapy, and certain medical conditions. Artificial saliva can help to alleviate the symptoms of dry mouth, including dryness of the mouth and throat, difficulty speaking and swallowing, and a burning sensation in the mouth.

Request For Free Sample Report of "Artificial Saliva Market"@ https://www.persistencemarketresearch.com/samples/16891

The global artificial saliva market is expected to grow at a significant rate during the forecast period (2022-2027). This growth is driven by factors such as the increasing prevalence of dry mouth, the growing geriatric population, and the rising prevalence of chronic diseases. In addition, the increasing use of artificial saliva in the treatment of dry mouth caused by radiation therapy and chemotherapy is expected to drive market growth.

The artificial saliva market can be segmented based on product type, distribution channel, and region. Based on product type, the market can be divided into spray, gel, and liquid. The spray segment is expected to dominate the market due to its ease of use and fast-acting nature. Based on distribution channel, the market can be segmented into hospitals, pharmacies, and online stores. The hospitals segment is expected to dominate the market due to the high prevalence of dry mouth in hospitalized patients.

Companies

GlaxoSmithKline plc
Cipla Limited
Mission Pharmacal Company
Fresenius Kabi
Parnell Pharmaceuticals, Inc.
CCMed Group
Entod International
Midatech Pharma Plc.
Forward Science
Valeant Pharmaceuticals International, Inc.
Biocosmetics Laboratories
Icpa Health Products LTD.
Perrigo
Laboratorios Kin, S.A.

Buy Full Report Now @ https://www.persistencemarketresearch.com/checkout/16891

Geographically, the artificial saliva market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to dominate the market due to the high prevalence of dry mouth, the presence of a large geriatric population, and the presence of advanced healthcare infrastructure. Europe is also expected to hold a significant share of the market due to the high prevalence of dry mouth and the presence of a large geriatric population.

Some of the key players operating in the artificial saliva market include GlaxoSmithKline plc, 3M, Bausch Health Companies Inc., Oasis Medical, Inc., and GC Corporation. These companies are focusing on research and development activities to introduce new and innovative products in the market.

In conclusion, the global artificial saliva market is expected to grow at a significant rate during the forecast period due to the increasing prevalence of dry mouth, the growing geriatric population, and the rising prevalence of chronic diseases. The increasing use of artificial saliva in the treatment of dry mouth caused by radiation therapy and chemotherapy is also expected to drive market growth.

Oral sprays and oral liquids opted for most in the artificial saliva market

The oral sprays segment had the maximum revenue share in the artificial saliva market at the end of 2016 and is highly likely to remain so at the end of the forecast period. The oral spray segment was valued at just under US$ 130 million in 2016 and should push past US$ 445 million by end 2025. Oral sprays are preferred in the artificial saliva market because they are both convenient and affordable.

The oral liquid segment was the second most popular in the artificial saliva market and is on track to record a CAGR of 14.2% for the period. Oral liquids had a market attractiveness index of 1.5 and key stakeholders in the artificial saliva market are advised to take this into consideration.

Request Customization @ https://www.persistencemarketresearch.com/request-customization/16891

Artificial Saliva Market Taxonomy

Product Type
Oral Spray
Oral Solution
Oral Liquid
Gel
Powder
Age Group
Adult
Paediatric
Distribution Channel


Hospital Pharmacies
Retail Pharmacies
Mail Order Pharmacies
Hypermarkets and Supermarkets
Region
North America
Latin America
Europe
Asia Pacific
Middle East and Africa

For More Premium Insights, Check out the Link:

Primary Hepatocytes Market - https://www.persistencemarketresearch.com/market-research/primary-hepatocytes-market.asp

Oncology Mice Models Market- https://www.prnewswire.com/news-releases/oncology-mice-models-market-with-an-estimated-growth-rate-of-6-over-the-decade-persistence-market-research-301531935.html

Asean Dysphagia Diet Thickening Agents Market - https://www.persistencemarketresearch.com/market-research/asean-dysphagia-diet-thickening-agents-market.asp

Media Contact:
Persistence Market Research
305 Broadway,7th Floor New York City, NY 10007 United States
Call +1-646-568-7751
Call +1 800-961-0353
sales@persistencemarketresearch.com

About Us

Persistence Market Research's Expertise in Life Sciences and Transformational Health

Our expert team of industry analysts comprising management graduates, medical professionals, engineers, and project managers provides insights on emerging therapy areas, diagnostic tools, medical devices and components, reimbursement and market access, biotechnology, and life science research products and services to equip decision-makers with sound inputs and strategic recommendations. Click here to learn more about how we zero in on the critical aspects of this industry.

This release was published on openPR.